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Abstract
 The Zika virus (ZIKV) caused a large outbreak in theBackground:
Americas leading to the declaration of a Public Health Emergency of
International Concern in February 2016. A causal relation between infection
and adverse congenital outcomes such as microcephaly was declared by
the World Health Organization (WHO) informed by a systematic review
structured according to a framework of ten dimensions of causality, based
on the work of Bradford Hill. Subsequently, the evidence has continued to
accumulate, which we incorporate in regular updates of the original work,
rendering it a living systematic review.
 We present an update of our living systematic review on theMethods:
causal relation between ZIKV infection and adverse congenital outcomes
and between ZIKV and GBS for four dimensions of causality: strength of
association, dose-response, specificity, and consistency. We assess the
evidence published between January 18, 2017 and July 1, 2019.
 We found that the strength of association between ZIKV infectionResults:
and adverse outcomes from case-control studies differs according to
whether exposure to ZIKV is assessed in the mother (OR 3.8, 95% CI:
1.7-8.7, I =19.8%) or the foetus/infant (OR 37.4, 95% CI: 11.0-127.1, I
=0%). In cohort studies, the risk of congenital abnormalities was 3.5 times
higher after ZIKV infection (95% CI: 0.9-13.5, I =0%). The strength of
association between ZIKV infection and GBS was higher in studies that
enrolled controls from hospital (OR: 55.8, 95% CI: 17.2-181.7, I =0%) than
in studies that enrolled controls at random from the same community or
household (OR: 2.0, 95% CI: 0.8-5.4, I =74.6%). In case-control studies,
selection of controls from hospitals could have biased results.
 The conclusions that ZIKV infection causes adverseConclusions:
congenital outcomes and GBS are reinforced with the evidence published
between January 18, 2017 and July 1, 2019.
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Introduction
The Zika virus (ZIKV), a mosquito-borne flavivirus, caused a 
large outbreak of infection in humans in the Americas between 
2015–2017 (WHO Zika -Epidemiological Update). Since 
then, the circulation of ZIKV has decreased substantially in 
the Americas1 but ZIKV transmission will likely continue at a 
lower level2. Smaller outbreaks have been reported from coun-
tries in Africa and Asia, including Angola, India3, and Singapore4. 
Regions with endemic circulation, such as Thailand5, have 
the potential for new ZIKV outbreaks with adverse outcomes6.
The World Health Organization (WHO) declared ZIKV as 
a cause of adverse congenital outcomes and Guillain-Barré 
syndrome (GBS) as early as September 20167, informed by a 
systematic review of evidence structured according to a frame-
work of ten dimensions of causality, based on Bradford Hill 
(Table 1)8. The accumulation of evidence on the adverse 
clinical outcomes of ZIKV has barely slowed down since the 
WHO declared the Public Health Emergency of International 
Concern (PHEIC) on February 1st, 2016, with approximately 
250 research publications on ZIKV appearing every month 
(see Zika Open Access Project). We updated the systematic 
review to January 18, 2017 as a living systematic review by 
introducing automated search methods to produce a high qual-
ity, up to date, online summary of research9 about ZIKV and its 
clinical consequences, for all the causality dimensions10.
Since 2017, understanding about the pathogenesis of how ZIKV 
causes congenital abnormalities has evolved11,12. The quality 
of diagnostic methods, especially for acute ZIKV infection, 
has also improved13–15. More importantly, understanding of the 
limitations of diagnostic testing, and the need for interpreta-
tion in the context of other flavivirus infections, has developed. 
Important epidemiological questions about the associations 
between ZIKV infection and adverse congenital outcomes and 
GBS remain unanswered, however. Much of the early epide-
miological evidence, which relied on surveillance data, was 
limited in use because of issues with the quality of the report-
ing and case definitions. The reported strength of association 
between ZIKV and adverse outcomes has varied in studies of 
different designs and in different settings. Evidence for a dose-
response relationship with higher levels of exposure to ZIKV 
resulting in more severe outcomes, of clinical findings that 
are specific to ZIKV infection, or of adverse outcomes caused 
by different lineages of ZIKV was not found in the earlier 
systematic reviews.
The objective of this study is to update epidemiological 
evidence about associations between ZIKV infection and adverse 
congenital outcomes and between ZIKV and GBS for four 
dimensions of causality: strength of association, dose-response, 
specificity, and consistency.
Methods
We performed a living systematic review, which we have described 
previously10. This review updates the findings of the previ-
ous reviews8,10 and will be kept up to date, in accordance with 
the methods described below. Reporting of the results follows 
Table 1. Comparison of the search strategy included study designs and causality dimensions addressed in the different review 
periods. The latest and previous versions of this table are available as extended data16.
Review Baseline8 Update 110 Update 2 [this review]
Period <May 30, 2016 May 30, 2016-January 18, 2017 >January 18, 2017 -July 01, 2019
Search strategy “ZIKV” or “Zika” “ZIKV” or “Zika” Focussed search strategy (Supplementary 
File 2)
Study design Epidemiological studies; in vivo/in vitro studies; 
surveillance reports
Epidemiological studies
Dimensions of the causality 
framework based on Bradford Hill*
•  Temporality (cause precedes effect)
•  Biological plausibility of proposed biological 
mechanisms
•  Strength of association •  Strength of association
•  Exclusion of alternative explanations
•   Cessation (reversal of an effect by experimental 
removal of, or observed a decline in, the exposure)
•  Dose-response relationship •  Dose-response relationship
•  Experimental evidence from animal studies
•   Analogous cause-and-effect relationships found in 
other diseases
•  Specificity of the effect •  Specificity of the effect
•   Consistency of findings across different study 
types, populations and times
•   Consistency of findings across different 
study types, populations and times
* The causality framework is described elsewhere in detail:
[https://f1000researchdata.s3.amazonaws.com/supplementary/13704/95380c74-7569-4049-bf3b-b2832794bdf9.docx].
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the Preferred Reporting Items of Systematic reviews and Meta-
Analyses (PRISMA) statement (Extended data, Supplementary 
File 117)18.
Focus on epidemiological aspects of causality
This review and subsequent updates will focuse on four dimen-
sions of causality that are examined in epidemiological study 
designs: strength of association, dose-response relationship and 
specificity of effects and consistency of association (Extended 
data, Table 1, Supplementary File 217). Evidence for domains 
of causality that are typically investigated in in vitro and 
in vivo laboratory studies (Table 1) was not sought. In the 
absence of licensed vaccines or treatments for ZIKV infection, 
we did not search for evidence on the effects of experimental 
removal of ZIKV.
Eligibility criteria
We considered epidemiological studies that reported original 
data and assessed ZIKV as the exposure and congenital abnor-
malities or GBS as the outcomes. We based the exposure and 
outcome assessment on the definitions used in the publications. 
We applied the following specific inclusion criteria (Extended 
data, Supplementary File 217):
Strength of association: at the individual level, we selected 
studies that included participants both with and without expo-
sure to ZIKV (Figure 1), such as cohort studies and case- 
control studies. At the population level, we included studies that 
assessed the outcome during the ZIKV outbreak and provided a 
comparison with pre or post-outbreak incidence of the outcome.
Dose-response relationship: we included studies that assessed 
the relation between the level of the viral titre or the presence 
or severity of the symptoms and the occurrence or severity of 
the outcome.
Specificity of the outcome for ZIKV exposure: we included 
studies that assessed whether the pathological findings in cases 
with the outcome are specific for ZIKV infection.
Consistency: we looked at eligible studies to determine the 
consistency of the relationship between ZIKV exposure and the 
outcomes across populations, study designs, regions or strains.
Search and information sources
We searched PubMed, Embase, LILACS and databases and 
websites of defined health agencies (Extended data, Supple-
mentary File 217). We included search terms for the exposure, 
the outcome and specific study designs. We also performed 
searches of the reference lists of included publications. A detailed 
search strategy is presented in Supplementary File 2. For this 
review, the search covered the period from January 19, 2017 to July 
1, 2019.
Study selection and extraction
One reviewer screened titles and abstracts of retrieved publica-
tions. If retained, the same reviewer screened the full text for 
inclusion. A second reviewer verified decisions. One reviewer 
extracted data from included publications into piloted extrac-
tion forms in REDCap (version 8.1.8 LTS, Research Electronic 
Data Capture)19. A second reviewer verified data entry. Conflicts 
were resolved by consulting a third reviewer.
Synthesis of evidence
First, we summarised findings for each dimension of causal-
ity and for each outcome descriptively. Where available, we 
calculated unadjusted odds ratios (OR) or risk ratios (RR) and 
their 95% confidence interval (CI) from published data for 
unmatched study designs. For matched study designs, we used 
the effect measure and 95% CI presented by the authors. For 
publications that presented results for multiple measures of 
exposure and/or outcome, we compared these results. We 
applied the standard continuity correction of 0.5 for zero val-
ues in any cell in the two-by-two table20. We used the I² statistic 
to describe the percentage of variation across studies that is due 
to heterogeneity for reasons other than chance21. Quantitative 
synthesis was performed using R 3.5.122. We conducted ran-
dom effects meta-analyses using the R package metafor (version 
2.0-0)20. Finally, we compared descriptive and quantitative 
Figure 1. For congenital abnormalities due to ZIKV, exposure assessment in mother-infant pairs can be performed in the mother or 
the foetus or infant. The latest and previous versions of this figure are available as extended data16.
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findings from this review period with previous versions of the 
review8,10.
Searching and screening frequency
Daily searches of PubMed, Embase and LILACS are auto-
mated and monthly searches are performed manually for other 
information sources in the first week of the month (Extended 
data, Supplementary File 217), with screening of all retrieved 
publications on the same day. The search strategy consisted 
of a combination of free terms and MESH terms that identi-
fied the exposure and outcomes (Extended data, Supplementary 
File 217). Searches from multiple sources were combined and 
automatically deduplicated by an algorithm that was tested 
against manual deduplication. Unique records enter a central 
database, and reviewers are notified of new content.
Frequency of results update
The tables and figures presented in this paper will be updated 
every six months as a new version of this publication. As soon 
as new studies are included, their basic study characteristics are 
extracted and provided online https://zika.ispm.unibe.ch/assets/
data/pub/causalityMap/.
Duration of maintenance of the living systematic review
We will keep the living systematic review up to date for as 
long as new relevant data are published and at least until 
October 31, 2021, the end date of the project funding.
Risk of bias/Certainty of evidence assessment
To assess the risk of bias of cohort studies and case-control stud-
ies, we compiled a list of questions in the domains of selec-
tion bias, information bias, and confounding, based on the 
quality appraisal checklist of the United Kingdom National 
Institute for Health and Care Excellence (NICE) and literature23. 
Two independent reviewers conducted the quality assessment. 
Disagreements were resolved by a third reviewer.
Results
Search results from January 19, 2017 to July 1, 2019 
(Update 2)
From January 19, 2017 to July 1, 2019 we screened 1941 publi-
cations, of which we included 638 based on title and abstract. 
After reviewing the full text, 249 publications were included 
(Table 2, Figure 3). Of these publications, 195 reported on 
congenital abnormalities linked to ZIKV24–217 and 59 on 
GBS4,44,118,201,203,206,218–270. Five outbreak reports described both 
outcomes44,118,201,203,206.
Adverse congenital outcomes
We included 39 case reports24–61, 62 case series62–123, 10 case-
control studies124–133, 35 cohort studies134–168, 19 cross-sectional 
studies169–187, seven ecological studies188–194, three modelling 
studies195–197 and 20 outbreak reports198–217 that report on congenital 
abnormalities linked to ZIKV.
Causality dimensions
Strength of association. Individual level: In this review period, 
five case-control studies reported on strength of association, 
four in Brazil (n=670 participants)125,126,128,130 and one in French 
Polynesia (n=123 participants)131. The studies assess adverse 
pregnancy outcomes including infants born with microcephaly, 
according to exposure to ZIKV for cases. Of these, all stud-
ies matched controls, based on gestational age and/or region. 
During the review period up to January 18, 2017, we included 
one case-control study271, which we replaced with a publica-
tion reporting the final results of the study126. The meta-analyses 
incorporate estimates from studies identified in all review 
periods.
Table 2. Included publications in the baseline review, update 1 and update 2 (this version), by 
outcome and epidemiological study design. The latest and previous versions of this table are 
available as extended data16.
Outcome Adverse congenital outcomes, 
number of publications
GBS, 
number of publications
Review period/version Baseline* Update1† Update2 Baseline* Update1† Update2
Study design
Case report 9 13 39 9 5 17
Case series 22 12 62 5 11 22
Case-control study 0 2 10 1 1 7
Cohort study 1 8 35 0 0 0
Cross-sectional study 2 1 19 0 1 3
Controlled trials 0 0 0 0 0 0
Ecological study/outbreak report 5 4 27 19 7 9
Modelling study 2 0 3 0 0 1
Total: 41 40 195 34 25 59
* Baseline review, earliest date of each information source to May 30, 20168;
† Update 1, May 30, 2016 to January 18, 201710.
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Assessment of exposure status varied between the studies 
(Extended data, Supplementary File 317). In five case-control 
studies, exposure to ZIKV was assessed in the mother, based 
on clinical symptoms of ‘suspected Zika virus infection’125, 
or presence of maternal antibodies measured by IgM (Kumar 
et al. (2016)272), PRNT (de Araujo et al. (2018)126, Subissi et al. 
(2018)131), or both PRNT and IgG (Moreira-Soto et al. (2018)) 
maternal antibody127.
In meta-analysis, we found that the odds of adverse congeni-
tal outcomes (microcephaly or congenital abnormalities) were 
3.8 times higher in ZIKV-infected mothers (95% CI: 1.7-8.7, 
tau2=0.18, I2=19.8%, Figure 4). Moreira-Soto et al. (2018) 
found that in Bahia, Brazil, Chikungunya infection was also 
associated with being a case127.
In two matched case-control studies, exposure to ZIKV was 
assessed in infants; Araujo et al. found a 73.1 (95% CI 13·0–Inf) 
times higher odds was reported for microcephaly when ZIKV 
infection was assessed by reverse transcription polymerase 
chain reaction (RT-PCR) in the neonate126. Krow-Lucal et al. 
(2018) found an OR of 21.9 (95% CI: 7.0-109.3) based 
on evidence of recent Zika infection assessed using IgM 
followed by PRNT in infants in Paraiba, Brazil128. When exposure 
was assessed at the infant-level, the combined odds of 
adverse congenital outcomes was 37.4 times higher (95% 
CI: 11.0-127.1, tau2=0, I2=0%, Figure 4).
In this review period, one cohort study reported on strength 
of association, in 610 pregnant women returning from ZIKV-
affected areas in Central and South America to the USA138. 
Maternal ZIKV exposure was measured using RT-PCR or 
IgM followed by plaque reduction neutralisation test (PRNT). 
Among the 28 infants born to ZIKV-infected mothers, none 
was diagnosed with microcephaly and, one was born with a 
major malformation. In the ZIKV-unexposed group, eight out 
of 306 had major malformations. A complete overview of dif-
ferent outcomes assessed is presented in the extended data, 
Supplementary File 317. During the review period up to Janu-
ary 18, 2017, we included two cohort studies, one in women 
with rash and fever (Brasil et al. (2016)) and one in unselected 
pregnant women (Pomar et al. (2017))273,274. In meta-analysis 
of all three studies, we found that the risk of microcephaly was 
3.5 times higher in ZIKV-infected mothers of babies (95% 
CI: 0.90-13.51, tau2=0, I2=0%, Figure 5).
Population level: At a population level, data from Mexico col-
lected at different altitudes during the ZIKV outbreak, showed 
Figure 2. Map of the epidemiological studies that report on adverse congenital outcomes (blue) or Guillain-Barré syndrome (red) 
associated with Zika virus exposure. The size of the points correspond with the number of exposed individuals with the adverse outcome, 
according to the definitions used in the publications. The latest and previous versions of this figure are available as extended data16.
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Figure 3. PRISMA flow-chart of publications retrieved, screened and included between January 18, 2017 and July 1, 2019. Adapted 
from: Moher et al. (2009)18. The latest and previous versions of this figure are available as extended data16.
that the risk of microcephaly was increased in regions at alti-
tudes below 2200m, in which ZIKV can circulate196. Hay et al. 
(2018) reanalysed surveillance data from Colombia and 
northeast Brazil and concluded that time-dependent report-
ing changes might have caused apparent inconsistencies in the 
proportion of congenital abnormalities as a result of maternal 
ZIKV infection197.
Dose response. Halai et al. (2017)120 examined the severity of 
congenital outcomes according to measures of the severity of 
maternal ZIKV infection in a subset of mothers in the cohort 
presented by Brasil et al. (2016)274. They evaluated ZIKV load, 
assessed by RT-PCR using the cycle threshold (CT) as a measure 
of number of RNA copies, and a severity score of symptoms in 
131 pregnant women. They concluded that neither higher viral 
load nor more severe symptoms was associated with more 
severe congenital abnormalities136. Moreira-Soto et al. found 
higher maternal antibody titers in microcephaly cases com-
pared with controls127. In previous review periods, Honein et al. 
(2016) compared outcomes in neonates born to symptomatic 
and asymptomatic infected pregnant women returning to the 
USA with possible ZIKV infection and found no differences275.
Specificity. Although some outcomes, such as lingual pheno-
type177 or neurogenic bladder276, have been hypothesised as a 
specific phenotype for congenital ZIKV infection, no additional 
evidence was identified that certain congenital adverse findings 
are specific for congenital ZIKV infection.
Consistency. Geographical region: All four WHO geographic 
regions (the Africa region [AFRO], the American region 
[AMRO], the South-East Asian region [SEARO] and the Western 
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Figure 4. Forest plot and meta-analysis of case-control studies reporting on ZIKV infection assessed in mothers (A) and in infants (B) and 
adverse congenital outcomes (microcephaly, congenital malformations, central nervous system abnormalities). The odds ratio from the five 
case-control studies that assess exposure in mothers combined is 3.8 (95% CI: 1.7-8.7, tau2=2.37, I2=19.8%); the odds ratio for the studies 
that assess exposure in infants is 37.4 (95% CI: 11.0-127.1, tau2=0, I2=0%). The odds ratios are plotted on the log scale. Abbreviations: CSF, 
cerebrospinal fluid, PRNT, plaque reduction neutralisation test; RE, random effects; RT-PCR, reverse transcription polymerase chain reaction. 
The latest and previous versions of this figure are available as extended data16.
Figure 5. Forest plot and meta-analysis of cohort studies reporting on ZIKV infection and adverse congenital outcomes. The risk ratio 
from the random effects model is 3.5 (95% CI: 0.9-13.5, tau2=0,I2=0%). The risk ratios are provided on the log scale. Abbreviations: ZIKV, Zika 
virus; PRNT, plaque reduction neutralisation test; RE, random effects; RT-PCR, Reverse transcription polymerase chain reaction. The latest 
and previous versions of this figure are available as extended data.
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Pacific region [WPRO]) with past or active ZIKV transmis-
sion have now reported congenital abnormalities due to ZIKV 
infection. During this review period, the first congenital abnor-
mality due to infection with the Asian lineage of the virus on the 
African mainland occurred in a traveller returning from Angola47. 
Possible cases of congenital abnormalities have occurred in 
Guinea-Bissau96. In the most recent WHO situation report 
from March 2017, two cases of microcephaly are documented 
in Thailand and one in Vietnam, which were also described 
in detail in other works24,54,107. We identified another publi-
cation on congenital abnormalities due to endemic ZIKV in 
Cambodia110. The occurrence of congenital adverse outcomes 
in AFRO, SEARO, and WPRO seems sporadic, despite the 
endemic circulation of ZIKV. As noted above, the observed 
complication rate varied strongly between regions. Extended 
data, Supplementary File 3 provides a full overview of the 
published studies on congenital abnormalities per region and 
country17.
Traveller/non-traveller populations: In this update, we found 
further evidence that congenital abnormalities occurred in infants 
born to women travellers returning from ZIKV-affected areas 
and women remaining in those areas. In total, 25 publications 
report on 272 congenital abnormalities due to ZIKV infection in 
travellers27,29,30,32,34,36,38,42,45,56,58,61,89,94,98,109,117,122,123,137,140,151,153,166,173, 
with 109 publications reporting congenital abnormalities due to 
ZIKV in 2652 non travellers24–26,28,31,33,35,37,39–41,43,44,46–48,50,51,54,57,60, 
62–79,81,83–85,87,88,90–93,95–97,100,101,104–106,110–113,115,116,118,119,121,124–135, 
142–147,149,152,154,156–164,167,168,171,172,175–180,182,186
In this review period, evidence emerged that transmission 
through sexual contact with infected travellers also resulted in 
foetal infection58,59.
Study designs: The association between ZIKV infection 
and congenital abnormalities was consistent across different 
study designs (Table 2).
Lineages: We found no new evidence of consistency across 
different lineages from observational studies. The currently 
observed adverse congenital outcomes are linked to the ZIKV 
of the Asian lineage.
Risk of bias assessment
In all case-control studies, uncertainty about the exposure sta-
tus due to imperfect tests could result in a bias towards the null. 
Some studies might suffer from recall bias where exposure 
was assessed by retrospectively asking about symptoms125,131. 
For the cohort studies138,274, the enrolment criteria were based 
on symptomatology. As a result, even in the absence of evi-
dence of ZIKV, the unexposed groups might have had condi-
tions that were unfavourable to their pregnancy. We expect this 
to bias the results towards the null or underestimate the true 
effect. Owing to imperfect diagnostic techniques, both false 
positives (IgM, cross reactivity) and false negatives (due 
to the limited detection window for RT-PCR) might occur, 
potentially resulting in bias; the direction of this bias would 
often be towards the null. None of the studies controlled 
for potential confounding. Extended data, Supplementary 
File 4 provides the full risk of bias assessment of the studies 
included in the meta-analysis17.
GBS
During this review period, we included 17 case reports44,218–233, 
22 case series118,234–254, seven case-control studies4,255–260, one 
ecological study264, one modelling study265 and eight outbreak 
reports201,203,206,266–270 that reported on ZIKV infection and GBS.
Causality dimensions
Strength of association. Individual level. The number of stud-
ies reporting on the strength of association between ZIKV infec-
tion and GBS at an individual level increased substantially. 
We identified five case-control studies255–259 published since 
the previous update, which included one case-control study 
from French Polynesia277. All studies were matched for age 
and place of residence. In the studies from Brazil, Colombia, 
Puerto Rico and New Caledonia, temporal clustering of cases 
in association with ZIKV circulation was documented255–258. 
In Bangladesh, ZIKV transmission was endemic259. Exposure 
assessment was based on serology255,256 or a combination of 
RT-PCR and serology257–259. Extended data, Supplementary File 
3 shows the variability in ORs according to criteria for ZIKV 
exposure assessment, based on unmatched crude data extracted 
from each case-control study17.
Figure 6 shows the association between GBS and ZIKV infec-
tion, using the diagnostic criteria that were most similar across 
studies. Heterogeneity was considerable (I2=78.3%), but was 
reduced slightly after stratification based on the method of selec-
tion of controls. The summary OR was higher in studies that 
enrolled controls from hospital (OR: 55.8, 95% CI: 17.2-181.7, 
tau2=0, I2=0%)258,277 than in studies that enrolled controls at 
random from within the same community255–257 or from the same 
household259 (OR: 2.0, 95% CI: 0.8-5.4, tau2=0.46, I2=74.6%). 
Amongst studies with community controls, ORs were lower 
when enrolment and assessment took place several months 
after onset of symptoms255,256 than in studies with contempo-
raneous enrolment257,259. To further illustrate the heterogene-
ity in exposure assessment between and within the studies, 
we provide additional aggregations of the data in Extended data, 
Supplementary File 317.
Population level. At a population level, Mier-Y-Teran-Romero 
et al. (2018) found that the estimated incidence of GBS ranged 
between 1.4 (0.4–2.5) and 2.2 (0.8–5.0) per 10,000 ZIKV 
infections comparing surveillance/reported cases from Brazil, 
Colombia, Dominican Republic, El Salvador, French, Honduras, 
Puerto Rico, Suriname, Venezuela, and Micronesia. The across-
location minimum and maximum estimates were used to 
estimate an average risk of having GBS and being reported after 
ZIKV infection across locations of approximately 2.0 GBS cases 
per 10,000 infections (95% credible interval 0.5–4.5 per 10,000 
ZIKV infections)265.
Dose response. In a case-control study, Lynch et al. (2018) 
found higher titres of neutralising antibodies in ZIKV-infected 
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GBS cases than in patients with symptomatic ZIKV infection 
but without GBS260.
Specificity. Dirlikov et al. (2018) compared Puerto Rican GBS 
cases reported through public health surveillance that were pre-
ceded by ZIKV and cases that were not preceded by ZIKV 
infection249. Clinical features involving cranial nerves were 
observed more frequently in ZIKV-related cases and, at a six-
month follow-up visit, residual cranial neuropathy was noted 
more often in this group. However, clinical symptoms 
did not allow a distinction to be made between ZIKV and 
non-ZIKV related GBS.
Consistency. Geographical region: During this review period, 
GBS likely due to ZIKV infection was reported in Asia; includ-
ing Thailand, Bangladesh, Singapore and India4,48,252,259. 
Publication in the WHO Region of the Americas followed the 
pattern as observed before and no GBS linked to ZIKV infec-
tion was reported in Africa. Extended data, Supplementary 
File 3 provides a full overview of the published studies on 
congenital abnormalities by region and country17. In a rean-
alysis of surveillance data from the Region of the Americas, 
Ikejezie et al. (2016) found consistent time trends between 
GBS incidence and ZIKV incidence264.
Traveller/non-traveller populations: In studies included 
in this update, we found additional evidence of GBS in 
both travellers and non-travellers with ZIKV infection. Ten 
publications report on 11 travellers218,220,222–224,227,229,232–234, 
while 34 publications report GBS due to ZIKV in 402 non 
travellers4,44,118,219,221,225,226,228,230,231,235–237,239–247,249,251,253–260,262,263.
Study designs: Across the different study designs, the rela-
tion between GBS and ZIKV is consistently shown. Table 2 
and Extended data, Supplementary File 3 provide an overview 
of the included study designs17.
Lineages: We still lack evidence on the consistency of the rela-
tion between GBS and ZIKV across different lineages from 
observational studies. The observed cases of GBS were linked to 
ZIKV of the Asian lineage.
Risk of bias assessment
Potential selection bias in case-control studies was introduced 
by the selection of controls from hospitals rather than from the 
communities in which the cases arose258,277. Uncertainty about 
the exposure status due to imperfect tests would tend to result 
in a bias towards the null. Two case-control studies did not 
conduct a matched analysis although controls were matched, 
and no study controlled for potential confounding by factors 
other than those used for matching. Exclusion criteria and par-
ticipation rate, especially of the controls, were poorly reported. 
Extended data, Supplementary File 4 provides the full risk of 
bias assessment of the studies included in the meta-analysis17.
Discussion
In this living systematic review, we summarised the evidence 
from 249 observational studies in humans on four dimensions 
Figure 6. Forest plot of six included case-control studies and their exposure assessment. Odds ratios (ORs) are shown on the log-
scale. The meta-analysis is stratified by the selection of controls: Hospital controls, or community/household controls. Most similar exposure 
assessment measures are compared (IgM256,258,259,277, recent flavivirus infection255, or IgM and/or RT-PCR257). OR: 7.0 [95% CI: 1.7-28.8, 
tau2=2.78, I2=78.3%]. ORs from studies marked with an asterisk (*) are matched ORs, unmarked studies provided crude ORs. The latest and 
previous versions of this figure are available as extended data16.
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of the causal relationship between ZIKV infection and adverse 
congenital outcomes and GBS, published between January 
18, 2017 and July 1, 2019.
Strengths and limitations
The strengths of this living systematic review are, first, that we 
automated much of the workflow10; we searched both interna-
tional and regional databases daily and we screen papers for eli-
gibility as they became available, so publication bias is unlikely. 
Second, we have quantified the strength of association between 
ZIKV infection and congenital abnormalities and GBS and 
investigated heterogeneity of outcome and exposure assessment 
within and between studies. Third, for congenital out-
comes, we included studies with both microcephaly and other 
possible adverse outcomes, acknowledging the spectrum of 
congenital adverse outcomes caused by ZIKV. This work 
also has several limitations. First, we have not assessed the 
dimensions of the causality framework that involve labora-
tory studies, so we have not updated the pathobiology of ZIKV 
complications, which was addressed in the baseline review8 
and the first update to January 201710. Limiting the review to 
epidemiological domains has allowed more detailed analy-
ses of these studies and we hope that laboratory scientists will 
continue to review advances in these domains. Second, the 
rate of publications on ZIKV remains high so, despite the 
reduced scope and automation, maintenance of the review 
is time-consuming and data extraction cannot be automated. 
Third, this review may suffer from continuity bias, which is 
important for the conduct and interpretation of living sys-
tematic reviews and results from changes in the author team. 
Careful adherence to the protocol will reduce this risk.
Interpretation of the findings
ZIKV and congenital abnormalities: Since the earlier ver-
sions of the review8,10, evidence on the causal relationship 
between ZIKV infection and congenital abnormalities has 
expanded. Unfortunately, the total number of cases investi-
gated in the published cohort or case-control studies remains 
small. In case-control studies in which infants with micro-
cephaly or other congenital abnormalities are compared with 
unaffected infants, the strength of association differs accord-
ing to whether exposure to ZIKV is assessed in in the mother 
(OR 3.8, 95% CI: 1.7-8.7, tau2=0.18, I2=19.8%) or the 
foetus/infant (OR 37.4, 95% CI: 11.0-127.1, tau2=0, I2=0%). 
This large difference in effect size can be attributed to the fact 
that not all maternal ZIKV infections result in foetal infec-
tion. In cohort studies, the risk of congenital abnormalities 
was 3.5 times higher (95% CI: 0.9-13.5, I2=0%, tau2=0) in 
mothers with evidence of ZIKV infection than without, which 
is similar to the OR for maternal exposure to ZIKV estimated 
from case-control studies. Further research is needed to under-
stand the drivers of mother to child transmission. Higher mater-
nal antibody titres were correlated with a higher incidence 
of adverse congenital outcomes in one case-control study127. 
However, amongst ZIKV-infected mothers followed prospec-
tively, severity of ZIKV infection was not associated with more 
severe congenital abnormalities136. Convincing evidence on 
a dose-response relation is therefore still lacking.
ZIKV and GBS: Evidence on the causal relation between 
ZIKV infection and GBS has grown since our last review10. 
The body of evidence is still smaller than that for congenital 
abnormalities, possibly because GBS is a rare complication, 
estimated to occur in 0.24 per 1000 ZIKV infections277. In this 
review, the strength of association between GBS and ZIKV 
infection, estimated in case-control studies, tended to be lower 
than observed in the first case-control study reported by Cao-
Lormeau (2016) in French Polynesia277. It is possible that the 
finding by Cao-Lormeau et al. was a ‘random high’, a chance 
finding278. Simon et al., however, found a similarly strong 
association in a case-control study in New Caledonia258. In 
both these studies, controls were patients in the same hos-
pital. Although matched for place of residence, it is possi-
ble that they were less likely to have been exposed to ZIKV 
than the cases, resulting in an overestimation of the OR. In 
case-control studies in which controls were enrolled from the 
same communities as the cases, estimated ORs were lower, 
presumably because exposure to ZIKV amongst community-
enrolled controls is less biased than amongst hospital controls279. 
Under-ascertainment of ZIKV infection in case-control 
studies in which enrolment occurred several months after 
the onset of symptoms255,256 is also likely to have reduced 
the observed strength of association. There is also possible 
evidence of a dose-response relationship, with higher levels of 
neutralising antibodies to both ZIKV and dengue in people with 
GBS260. However, the level of antibody titre might not be an 
appropriate measure of viral titre, and merely a reflection of 
the intensity of the immune response. Taking into account the 
entire body of evidence, inference to the best explanation280 
supports the conclusion that ZIKV is a cause of GBS. The 
prospect of more precise and robust estimates of the strength of 
association between ZIKV and GBS is low because outbreaks 
need to be sufficiently large to enrol enough people with GBS. In 
the large populations that were exposed during the 2015–2017 
outbreak, herd immunity will limit future ZIKV outbreaks.
Implications for future research
The sample sizes of studies published to date are smaller 
than those recommended by WHO for obtaining precise 
estimates of associations between ZIKV and adverse outcomes 
[Harmonization of ZIKV Research Protocols to Address Key 
Public Health]. Given the absence of large new outbreaks of 
ZIKV infection in 2017–2019, there is a need for consortia of 
researchers to analyse their data in meta-analyses based on indi-
vidual participant data [Individual Participant Data Meta-analy-
sis of Zika-virus related cohorts of pregnant women (ZIKV 
IPD-MA)]. Future collaborative efforts will help to quantify the 
absolute risks of different adverse congenital outcomes and allow 
investigation of heterogeneity between studies136,149,275.
This review highlights additional research gaps. We did not 
assess the complication rates within the infected group in stud-
ies without an unexposed comparison group; the adverse out-
comes are not pathognomonic for ZIKV infection, making an 
appropriate comparison group necessary. Although there are 
no individual features of ZIKV infection that are completely 
specific, the growing number of publications on ZIKV will 
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allow better ascertainment of the features of a congenital Zika 
syndrome281. In this review, we did not take into account the 
performance of the diagnostic tests in assessing the strength 
of association. Future research should include robust valida-
tion studies, and improved understanding of contextual factors 
in the performance of diagnostic tests, including the influence 
of previous circulation of other flaviviruses, the prevalence of 
ZIKV and the test used.
This living systematic review will continue to follow stud-
ies of adverse outcomes originating from ZIKV circulation in 
the Americas, but research in regions with endemic circula-
tion of ZIKV is expected to increase. Such studies will clarify 
whether ZIKV circulation in Africa and Asia also results in 
adverse outcomes, as suggested by the case-control study of 
GBS from Bangladesh259. Increased awareness might improve the 
evidence-base in these regions, where misperceptions about 
the potential risks of ZIKV-associated disease with differ-
ent virus lineages has been reported282. An important outstand-
ing question remains whether the absence of reported cases 
of congenital abnormalities or GBS in these regions represent 
a true absence of complications or is this due to weaker sur-
veillance systems or reporting283. The conclusions that ZIKV 
infection causes adverse congenital outcomes and GBS are 
reinforced with the evidence published between January 18, 
2017 and July 1, 2019.
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